Asthma is a chronic lung disease that narrows the tubes that help carry air both in and out of the lungs, i.e., the airways. Asthma causes the inside walls of your airways to become swollen and sore, making it hard for the air to pass out of the lungs. As a result of this, there are recurring periods of wheezing, coughing, shortness of breath, and tightness in chest, especially during the night and in the morning. When the symptoms of asthma become worse with time, it is referred to as an asthma attack. During a case of severe asthma attack, the airways get extremely close to one another causing the vital organs of the body to not get enough oxygen.
The Asthma Devices Market has experienced steady growth, driven by increasing prevalence of respiratory conditions and advancements in medical technology. Inhalers, spacers, and nebulizers remain the primary devices in this market, with inhalers holding the largest share due to their convenience and effectiveness in delivering medication directly to the lungs. The market is also witnessing a growing demand for smart inhalers, which offer real-time monitoring and data tracking to improve patient compliance. Regional analysis indicates that North America continues to dominate the market share, attributed to a higher incidence of asthma and greater access to advanced healthcare. However, emerging markets in Asia-Pacific are expected to see significant growth, fueled by rising awareness and improved healthcare infrastructure. Additionally, the trend towards personalized medicine is influencing the development of more targeted asthma therapies, further boosting the market. Overall, the Asthma Devices Market is poised for robust growth, supported by technological innovations and an increasing focus on patient-centered care.
The severity of the disease can be understood by the striking percentage of deaths caused due to asthma over the last few decades. This has led to the emergence of asthma devices or asthma inhalers. These devices deliver medication into the body through the lungs, thereby acting as a treatment for asthma and chronic obstructive pulmonary disease. Recognizing the potential of the devices, The Asthma Devices Market was valued at USD 4.00 billion in 2023. The global industry is expected to grow from USD 4.21 billion in 2024 to USD 7.45 billion by 2032, reflecting a compound annual growth rate (CAGR) of 4.89% during the forecast period (2024 - 2032).
The increasing prevalence of asthma disease is believed to be one of the key drivers of the market. As per the statistics published by the World Health Organization (WHO), a total of 235 million people suffered from asthma in 2017. Thus, showcasing the prevalent nature of this disease. Add to this, the surging healthcare expenditures and growing awareness concerning the disease are slated to fuel the market growth of asthma devices. At the same time, however, long-term treatment procedures coupled with the low per capita income and the lack of favorable policies in developing countries can restrict the growth of the global asthma devices market over the forecast period.
Competitive Landscape
The Global Asthma Devices Market number of key market players, including 3M (U.S.), Aristopharma Ltd. (Bangladesh) Merck & Co., Inc. (U.S.), Koninklijke Philips N.V. (Netherlands), AstraZeneca (U.K.), SRS Pharmaceuticals Pvt. Ltd. (India), GlaxoSmithKline PLC (U.K.), Boehringer Ingelheim GmbH (Germany), Baxter (U.S.), and others.
Segmentation
The Global Asthma Devices Market segmentation is done on the basis of technology, type, and end-users.
By technology, the market segments into digitally operated inhaler devices, manually operated inhaler devices, and other devices.
By type, the market includes nebulizers, inhalers, and others. The inhalers segment is further divided into dry powder and metered-dose inhalers. The metered-dose inhalers segment is narrowed down into metered-dose inhalers with a spacer, standard pressurized metered-dose inhalers, breath-activated pressurized metered-dose inhalers, and others. The nebulizers segment is segmented further into ultrasonic nebulizers, compressor nebulizers, mesh nebulizers, and others.
By end-users, the market comprises of retail pharmacies, hospitals, clinics, and others.
Regional Analysis
The geographical segmentation of the asthma devices market insights includes the following regions: America, Asia-Pacific, Europe, and the Middle East & Africa.
Americas spearhead the global market for asthma devices due to a well-established healthcare sector and a huge patient population base for asthma diseases. Also, changing consumer lifestyle and increasing healthcare-related expenditure is believed to also fuel the market. And, with the towering presence of global players like Baxter and Merck & Co. Inc. as well as others, the region is expected to hold on to its top position during the forecast period.
Following Americas, Europe is the second-largest regional market for asthma devices in the world. This is primarily due to the established healthcare infrastructure and the huge population of asthma patients. Add to this, government support for R&D and rising expenditures in healthcare are anticipated to fuel the market growth as well. The presence of developed countries like Germany, the UK, and France too contribute to the market’s growth in this region.
Asia-Pacific is the fastest-growing regional market as compared others, due to the huge pool of patient population and continuously developing economies like China and India. Favorable measures undertaken by the government like reduced excise and customs duty as well as the various exemptions in service tax are also expected to boost the market growth of asthma devices.
Finally, the Middle East & Africa regions hold the least market share because of the presence of a poor economy, lack of healthcare infrastructure, and strict and unfavorable government policies.
Related Report
Aminoglycoside Antibiotics Market
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian